Home » Phase III Studies Show Stelara Inhibits Structural Damage in Psoriatic Arthritis Patients
Phase III Studies Show Stelara Inhibits Structural Damage in Psoriatic Arthritis Patients
Results from two Phase III trials of Janssen’s Stelara show the drug more effectively prevents structural damage from psoriatic arthritis when compared with a placebo.
News Medical
News Medical
Upcoming Events
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May